About the North American Neuromodulation Society's Annual Meeting

Letter from the Scientific Program Chair and NANS President

We are thrilled to invite you to the NANS 23rd Annual Meeting — the world’s largest assembly in the field of neuromodulation! The 2020 meeting will showcase the latest advances in the field through cutting edge plenary sessions, presentations, and posters, as well as exhibitions from numerous device companies. Last year, NANS was proud to host participants from more than 20 countries. NANS offers attendees an opportunity to network with colleagues and potential collaborators, serving as the premier meeting for advancing the science and practice of neuromodulation.

We have an extensive and exciting pre-meeting educational program scheduled for Thursday, January 23, 2020. New to the NANS Annual Meeting is the "Engineering Principles of Spinal Cord Stimulation and Deep Brain Stimulation for Clinicians" course as well as two half-day courses — the “Spinal Cord Stimulation Programming: Basics, Science, Coding” course and the “Introduction to Intraoperative Neuromonitoring for Spinal Cord Stimulation” course. We are excited that the Leadership Course is taking place again this year, but under its new name — the “Professional Development Workshop.” The course will host nationally renowned speakers who will discuss best practice management, leadership skills, and practice strategies. The Advanced Practice Provider Course continues to grow in popularity and for its 11th year will provide an overview of neuromodulation topics. There also is the full-day course, “Controversies in Intrathecal Therapy,” which will review the principles of intrathecal therapy management. Thursday’s program includes our popular “Neuromodulation for Advanced Implantable Therapies: A Hands-On Cadaver Course for Neurosurgery Residents and Pain Fellows,” combining didactic lectures and hands-on training. This year’s offerings also include the "Neurology Neuromodulation Workshop," the "Hands-On Cadaver Course for Engineers," and two separate Certificate of Attendance courses. The "Certificate of Attendance: Advanced Neuraxial Neuromodulation" course will focus on the evidence-based and appropriate utilization of implantable therapies for pain management, while the "Certificate of Attendance: Peripheral Nerve Stimulation" course will provide evidence-based and expert-driven instruction on peripheral nerve stimulation.

The theme of the NANS 23rd Annual Meeting is “Driving Innovation Through Science and Evidence.” In recent years, scientific advances and novel research have generated an unprecedented amount of evidence for new indications in neuromodulation. Novel understandings of mechanisms and effects of neuromodulation have driven these innovations. Amidst a seemingly never-ending stream of new information, determining the best therapy for the patient in front of you can prove difficult. Our program will dissect this mountain of evidence and present the most novel innovations to help health care professionals translate the science into outcomes for their patients. As the field of neuromodulation expands to indications beyond pain, attendees will have the chance to explore exciting new therapeutic options for a multitude of patients. Plenary sessions on both Friday, January 24, and Saturday, January 25, will span a diverse range of topics targeted at translating innovation to outcomes. Subjects will include a thorough discussion of neuromodulation patient selection, benefits, and ethics; the importance of the placebo effect in your daily practice; a critical appraisal of the available data, the value of RCTs, retrospective studies, and registry data; and, finally, how this data and innovation influences patient care. These sessions will culminate on Saturday with our Keynote Speaker, Dr. Linda Watkins, discussing the translational approach to understanding the roles of non-neuronal cells in neuromodulation and pain.

Concurrent sessions on Friday and Saturday afternoon will cover crucial developments in neuromodulation. Both interventional and non-interventional topics will be discussed, as well as the role of industry collaboration in innovation, advocacy, healthcare policy, management of psychological and movement disorders, and other non-pain pathologies. Multiple sessions will be dedicated to a deeper understanding of basic science research and engineering, which have served as the driving force behind neuromodulation’s recent renaissance. Additionally, NANS is proud to continue the strong collaboration with other societies to expand pain knowledge through sessions chaired by the American Academy of Pain Medicine, the American Society of Regional Anesthesia and Pain Medicine, and the Spine Interventional Society. These sessions will discuss the influence of mental health disorders on chronic pain and spinal cord stimulation, the widespread impact of opioids on the continuum of care, the emerging role of interventionalists in headache medicine, predictive factors for outcomes, and advances in radiofrequency ablation.

We look forward to welcoming you to Las Vegas for this world-class event and the largest meeting of its kind dedicated to the field of neuromodulation. In addition to the excellent educational opportunities offered at this meeting, we will have multiple social events that will allow faculty and attendees from a variety of disciplines to interact. We anticipate the NANS 23rd Annual Meeting to be a memorable educational and networking experience for all.

Ricardo Vallejo, MD PhD
Scientific Program Chair

B. Todd Sitzman, MD MPH
NANS President